Analyst Price Targets — ADUS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 8, 2026 10:19 am | Andrew Mok | Barclays | $96.00 | $105.97 | TheFly | Addus HomeCare price target raised to $96 from $92 at Barclays |
| May 15, 2026 8:48 am | — | Barclays | $92.00 | $92.41 | TheFly | Addus HomeCare price target lowered to $92 from $102 at Barclays |
| February 25, 2026 1:53 pm | Ben Hendrix | RBC Capital | $139.00 | $103.08 | StreetInsider | RBC Capital on Addus HomeCare (ADUS): 'Post-4Q pull-back unwarranted' |
| February 24, 2026 10:21 am | — | Barclays | $112.00 | $117.63 | TheFly | Addus HomeCare price target lowered to $112 from $117 at Barclays |
| January 7, 2026 12:06 pm | Clarke Murphy | Truist Financial | $135.00 | $110.98 | TheFly | Addus HomeCare initiated with a Buy at Truist |
| November 4, 2025 10:07 am | Andrew Mok | Barclays | $117.00 | $118.99 | TheFly | Addus HomeCare price target raised to $117 from $111 at Barclays |
| September 2, 2025 9:10 am | — | UBS | $145.00 | $115.67 | TheFly | Addus HomeCare initiated with a Buy at UBS |
| December 16, 2024 9:50 am | Constantine Davides | JMP Securities | $150.00 | $122.96 | TheFly | Addus HomeCare initiated with an Outperform at JMP Securities |
| November 6, 2024 11:27 am | Scott Fidel | Stephens | $145.00 | $124.68 | StreetInsider | Addus HomeCare (ADUS) PT Raised to $145 at Stephens |
| October 10, 2024 5:49 pm | Matthew Gillmor | KeyBanc | $150.00 | $127.44 | TheFly | Addus HomeCare initiated with an Overweight at KeyBanc |
Latest News for ADUS
ADUS's business model has structural advantages that will allow it to withstand sector-wide pressures. With the federal crackdown among self-directed operators, ADUS is in a position to acquire client books for cheaper. As the US population ages and federal policies continue to pressure state budgets, ADUS stands to increasingly benefit from higher allocation to home care in its leading markets.
This healthcare provider delivers personal care, hospice, and home health services across 22 states, targeting vulnerable populations.
Addus HomeCare NASDAQ: ADUS executives said a new federal moratorium on certain home health licenses should have little effect on the company's growth plans, while highlighting continued improvement in personal care services trends and ongoing acquisition opportunities.
Addus HomeCare Corporation (ADUS) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Addus HomeCare Corporation (ADUS) Q1 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ADUS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.